RNTX

Rein Therapeutics
RNTX

23 hedge funds and large institutions have $1.15M invested in Rein Therapeutics in 2018 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 6 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

less ownership

Funds ownership: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

72% less capital invested

Capital invested by funds: $4.03M → $1.15M (-$2.88M)

Holders
23
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$304K
2
+$211K
3
+$60.3K
4
Citadel Advisors
Citadel Advisors
Florida
+$41.2K
5
TSS
Two Sigma Securities
New York
+$20.5K

Top Sellers

1
-$312K
2
-$253K
3
-$126K
4
AAP
Ardsley Advisory Partners
Connecticut
-$83K
5
Morgan Stanley
Morgan Stanley
New York
-$82.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
–
1
2